Published in Br J Cancer on November 07, 2006
The impact of S- and G2-checkpoint response on the fidelity of G1-arrest by cisplatin and its comparison to a non-cross-resistant platinum(IV) analog. Gynecol Oncol (2011) 1.13
Napsin A as a marker of clear cell ovarian carcinoma. BMC Cancer (2013) 0.92
Mechanism of DNA damage responses induced by exposure to an oligonucleotide homologous to the telomere overhang in melanoma. Oncotarget (2013) 0.89
Reactive oxygen species and p21Waf1/Cip1 are both essential for p53-mediated senescence of head and neck cancer cells. Cell Death Dis (2015) 0.84
Genetic variants of p27 and p21 as predictors for risk of second primary malignancy in patients with index squamous cell carcinoma of head and neck. Mol Cancer (2012) 0.83
Genetic variants of p21 and p27 and pancreatic cancer risk in non-Hispanic Whites: a case-control study. Pancreas (2010) 0.82
T0901317 inhibits cisplatin-induced apoptosis in ovarian cancer cells [corrected]. Int J Gynecol Cancer (2011) 0.79
Mitomycin C and decarbamoyl mitomycin C induce p53-independent p21WAF1/CIP1 activation. Int J Oncol (2016) 0.78
Recruitment of trimeric proliferating cell nuclear antigen by G1-phase cyclin-dependent kinases following DNA damage with platinum-based antitumour agents. Br J Cancer (2013) 0.78
Protein kinase inhibitors emodin and dichloro-ribofuranosylbenzimidazole modulate the cellular accumulation and cytotoxicity of cisplatin in a schedule-dependent manner. Cancer Chemother Pharmacol (2009) 0.77
Drug-dependent functionalization of wild-type and mutant p53 in cisplatin-resistant human ovarian tumor cells. Oncotarget (2016) 0.75
Insulin-like growth factor binding protein-3 is a new predictor of radiosensitivity on esophageal squamous cell carcinoma. Sci Rep (2015) 0.75
Evaluation of the cytotoxicity of the Bithionol - cisplatin combination in a panel of human ovarian cancer cell lines. BMC Cancer (2017) 0.75
Evaluation of the cytotoxicity of the Bithionol-paclitaxel combination in a panel of human ovarian cancer cell lines. PLoS One (2017) 0.75
Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem (1996) 45.70
Silver stain for proteins in polyacrylamide gels: a modified procedure with enhanced uniform sensitivity. Anal Biochem (1981) 29.21
p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell (1994) 8.90
Proteasome inhibitors: valuable new tools for cell biologists. Trends Cell Biol (1998) 7.27
A one-step purification of membrane proteins using a high efficiency immunomatrix. J Biol Chem (1982) 6.70
p21 is necessary for the p53-mediated G1 arrest in human cancer cells. Cancer Res (1995) 6.66
p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes Dev (1995) 5.63
Cyclin E-CDK2 is a regulator of p27Kip1. Genes Dev (1997) 5.49
The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J (1999) 5.44
The role of the cyclin-dependent kinase inhibitor p21 in apoptosis. Mol Cancer Ther (2002) 4.73
Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27. EMBO J (1997) 4.17
Ubiquitination of p27 is regulated by Cdk-dependent phosphorylation and trimeric complex formation. Genes Dev (1999) 4.07
Tumor susceptibility of p21(Waf1/Cip1)-deficient mice. Cancer Res (2001) 2.37
Deregulated degradation of the cdk inhibitor p27 and malignant transformation. Semin Cancer Biol (2003) 2.27
Redistribution of the CDK inhibitor p27 between different cyclin.CDK complexes in the mouse fibroblast cell cycle and in cells arrested with lovastatin or ultraviolet irradiation. Mol Biol Cell (1995) 2.18
Lovastatin-mediated G1 arrest is through inhibition of the proteasome, independent of hydroxymethyl glutaryl-CoA reductase. Proc Natl Acad Sci U S A (1999) 2.14
Multiple functions of p27(Kip1) and its alterations in tumor cells: a review. J Cell Physiol (2000) 1.94
p21 is a critical CDK2 regulator essential for proliferation control in Rb-deficient cells. J Cell Biol (1998) 1.59
p27Kip1 overexpression causes apoptotic death of mammalian cells. Oncogene (1997) 1.57
Promoting apoptosis: a novel activity associated with the cyclin-dependent kinase inhibitor p27. Cancer Res (1997) 1.50
Induction of p21 by p53 following DNA damage inhibits both Cdk4 and Cdk2 activities. Oncogene (2005) 1.43
Small-molecule cyclin-dependent kinase modulators. Oncogene (2003) 1.36
Differential effects of cell cycle regulatory protein p21(WAF1/Cip1) on apoptosis and sensitivity to cancer chemotherapy. Drug Resist Updat (2003) 1.34
Cell cycle control as a basis for cancer drug development (Review). Int J Oncol (2000) 1.16
Cell cycle deregulation: a common motif in cancer. Prog Cell Cycle Res (2003) 1.14
RNA silencing of S-phase kinase-interacting protein 2 inhibits proliferation and centrosome amplification in lung cancer cells. Oncogene (2005) 1.13
Synthesis, characterization and cytotoxicity of new platinum(IV) axial carboxylate complexes: crystal structure of potential antitumor agent [PtIV(trans-1R,2R-diaminocyclohexane)trans(acetate)2Cl2]. Bioorg Med Chem (2000) 1.10
The p21(cip1/waf1) cyclin-dependent kinase inhibitor enhances the cytotoxic effect of cisplatin in human ovarian carcinoma cells. Cancer Lett (2000) 1.09
Expression of p53 in cisplatin-resistant ovarian cancer cell lines: modulation with the novel platinum analogue (1R, 2R-diaminocyclohexane)(trans-diacetato)(dichloro)-platinum(IV). Clin Cancer Res (1999) 1.08
p21Cip1 and p27Kip1 induce distinct cell cycle effects and differentiation programs in myeloid leukemia cells. J Biol Chem (2005) 1.06
Spy1 interacts with p27Kip1 to allow G1/S progression. Mol Biol Cell (2003) 1.05
Induction of apoptosis by cisplatin and its effect on cell cycle-related proteins and cell cycle changes in hepatoma cells. Cancer Lett (2002) 1.04
Comparative effects of overexpression of p27Kip1 and p21Cip1/Waf1 on growth and differentiation in human colon carcinoma cells. Oncogene (1999) 0.95
Status of p53 phosphorylation and function in sensitive and resistant human cancer models exposed to platinum-based DNA damaging agents. J Cancer Res Clin Oncol (2003) 0.93
p27kip1 contributions to cancer. Prog Cell Cycle Res (2003) 0.88
The induction of cell cycle regulatory and DNA repair proteins in cisplatin-induced acute renal failure. Toxicol Appl Pharmacol (2004) 0.88
Activation of telomerase and its association with G1-phase of the cell cycle during UVB-induced skin tumorigenesis in SKH-1 hairless mouse. Oncogene (1999) 0.87
Modulation of cytotoxicity and cellular pharmacology of 1,2-diaminocyclohexane platinum (IV) complexes mediated by axial and equatorial ligands. Cancer Res (1993) 0.85
Mechanism of Cdk2/Cyclin E inhibition by p27 and p27 phosphorylation. Biochemistry (1999) 0.85
Induction of p21(CIP1/Waf1) and activation of p34(cdc2) involved in retinoic acid-induced apoptosis in human hepatoma Hep3B cells. Exp Cell Res (1999) 0.84
Cell cycle checkpoint status in human malignant mesothelioma cell lines: response to gamma radiation. Br J Cancer (2003) 0.84
Exogenous expression of p21(WAF1/CIP1) exerts cell growth inhibition and enhances sensitivity to cisplatin in hepatoma cells. Cancer Lett (2001) 0.84
Bimodal effects of 1R,2R-diaminocyclohexane(trans-diacetato)(dichloro)platinum(IV) on cell cycle checkpoints. Clin Cancer Res (2001) 0.83
Increased sensitivity of a metastatic model of prostate cancer to a novel tetravalent platinum analog. Prostate (2005) 0.83
Anti-sense oligonucleotide of p21(waf1/cip1) prevents interleukin 4-mediated elevation of p27(kip1) in low grade astrocytoma cells. Oncogene (2000) 0.80
Cell cycle-independent upregulation of p27Kip1 by p21Waf1 in K562 cells. Oncogene (2001) 0.79
UVB induced cell cycle checkpoints in an early stage human melanoma line, WM35. Oncogene (2000) 0.79
Changes in cyclins and cyclin-dependent kinases induced by DNA damaging agents in a human ovarian cancer cell line expressing mutated or wild-type P53. Exp Cell Res (1996) 0.79
Modulatory effect of axial and equatorial ligands on antitumor activities of trans-1R,2R-diaminocyclohexane platinum(IV) complexes. Anticancer Drug Des (1994) 0.77
p21 is a universal inhibitor of cyclin kinases. Nature (1993) 15.55
Argonaute2, a link between genetic and biochemical analyses of RNAi. Science (2001) 15.32
Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. Proc Natl Acad Sci U S A (1993) 10.36
Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature (1995) 9.86
Tetrahymena histone acetyltransferase A: a homolog to yeast Gcn5p linking histone acetylation to gene activation. Cell (1996) 9.86
Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation. Nat Genet (1998) 8.91
Carboplatin dosage: prospective evaluation of a simple formula based on renal function. J Clin Oncol (1989) 6.86
Condensins, chromosome condensation protein complexes containing XCAP-C, XCAP-E and a Xenopus homolog of the Drosophila Barren protein. Cell (1997) 5.86
Nucleosome assembly by a complex of CAF-1 and acetylated histones H3/H4. Cell (1996) 5.77
HDA1 and RPD3 are members of distinct yeast histone deacetylase complexes that regulate silencing and transcription. Proc Natl Acad Sci U S A (1996) 5.61
Sequence-specific and phosphorylation-dependent proline isomerization: a potential mitotic regulatory mechanism. Science (1997) 5.40
The RCAF complex mediates chromatin assembly during DNA replication and repair. Nature (1999) 5.27
ACF, an ISWI-containing and ATP-utilizing chromatin assembly and remodeling factor. Cell (1997) 5.22
Yeast origin recognition complex functions in transcription silencing and DNA replication. Science (1993) 4.85
Beta1-class integrins regulate the development of laminae and folia in the cerebral and cerebellar cortex. Neuron (2001) 4.62
Ultraviolet radiation sensitivity and reduction of telomeric silencing in Saccharomyces cerevisiae cells lacking chromatin assembly factor-I. Genes Dev (1997) 4.34
Bactericidal activity of photocatalytic TiO(2) reaction: toward an understanding of its killing mechanism. Appl Environ Microbiol (1999) 4.18
p19Skp1 and p45Skp2 are essential elements of the cyclin A-CDK2 S phase kinase. Cell (1995) 4.08
Cdc53 targets phosphorylated G1 cyclins for degradation by the ubiquitin proteolytic pathway. Cell (1996) 4.06
Phosphorylation and activation of 13S condensin by Cdc2 in vitro. Science (1998) 3.89
ACF consists of two subunits, Acf1 and ISWI, that function cooperatively in the ATP-dependent catalysis of chromatin assembly. Genes Dev (1999) 3.85
Reduced fertility and postischaemic brain injury in mice deficient in cytosolic phospholipase A2. Nature (1997) 3.70
Structure-based discovery of an organic compound that binds Bcl-2 protein and induces apoptosis of tumor cells. Proc Natl Acad Sci U S A (2000) 3.69
Structural clues to prion replication. Science (1994) 3.43
Nucleosomal DNA regulates the core-histone-binding subunit of the human Hat1 acetyltransferase. Curr Biol (1998) 3.40
Purification of Tetrahymena telomerase and cloning of genes encoding the two protein components of the enzyme. Cell (1995) 3.23
Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase. Proc Natl Acad Sci U S A (1998) 3.23
The p150 and p60 subunits of chromatin assembly factor I: a molecular link between newly synthesized histones and DNA replication. Cell (1995) 3.16
Hedgehog elicits signal transduction by means of a large complex containing the kinesin-related protein costal2. Cell (1997) 3.06
The multidomain structure of Orc1p reveals similarity to regulators of DNA replication and transcriptional silencing. Cell (1995) 3.05
Inhibition of interleukin 1beta converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage. Proc Natl Acad Sci U S A (1997) 2.99
A(2A) adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice. J Neurosci (1999) 2.92
Identification and characterization of SA/Scc3p subunits in the Xenopus and human cohesin complexes. J Cell Biol (2000) 2.91
Binding of hnRNP H to an exonic splicing silencer is involved in the regulation of alternative splicing of the rat beta-tropomyosin gene. Genes Dev (1999) 2.69
Characterization of the five replication factor C genes of Saccharomyces cerevisiae. Mol Cell Biol (1995) 2.69
The origin recognition complex in silencing, cell cycle progression, and DNA replication. Mol Biol Cell (1995) 2.67
Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment. Cell Death Dis (2013) 2.52
Drosophila NAP-1 is a core histone chaperone that functions in ATP-facilitated assembly of regularly spaced nucleosomal arrays. Mol Cell Biol (1996) 2.50
Early clinical studies with cis-diammine-1,1-cyclobutane dicarboxylate platinum II. Cancer Chemother Pharmacol (1982) 2.50
Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells. Oncogene (2008) 2.47
Replication focus-forming activity 1 and the Werner syndrome gene product. Nat Genet (1998) 2.47
Protein identifications for a Saccharomyces cerevisiae protein database. Electrophoresis (1994) 2.44
Complex synthetic chemical libraries indexed with molecular tags. Proc Natl Acad Sci U S A (1993) 2.44
Recovery of a virulent strain of newcastle disease virus from cloned cDNA: expression of a foreign gene results in growth retardation and attenuation. Virology (2000) 2.39
Chromosomal location of genes participating in the degradation of purines in Pseudomonas aeruginosa. Mol Gen Genet (1978) 2.34
Interaction between the Drosophila CAF-1 and ASF1 chromatin assembly factors. Mol Cell Biol (2001) 2.34
p62(dok): a constitutively tyrosine-phosphorylated, GAP-associated protein in chronic myelogenous leukemia progenitor cells. Cell (1997) 2.33
Myelin antigen-specific CD8+ T cells are encephalitogenic and produce severe disease in C57BL/6 mice. J Immunol (2001) 2.27
A TBP-TAF complex required for transcription of human snRNA genes by RNA polymerase II and III. Nature (1995) 2.20
Purification and characterization of human RNPS1: a general activator of pre-mRNA splicing. EMBO J (1999) 2.20
Calcium-regulated modulator protein interacting agents inhibit smooth muscle calcium-stimulated protein kinase and ATPase. Mol Pharmacol (1980) 2.18
Proteome studies of Saccharomyces cerevisiae: identification and characterization of abundant proteins. Electrophoresis (1997) 2.18
Systematic identification of mitotic phosphoproteins. Curr Biol (1997) 2.18
POU domain factor Brn-3b is essential for retinal ganglion cell differentiation and survival but not for initial cell fate specification. Dev Biol (1999) 2.11
Pharmacology of protein kinase inhibitors. Annu Rev Pharmacol Toxicol (1992) 2.08
A Saccharomyces cerevisiae Internet protein resource now available. Electrophoresis (1995) 2.07
Dual role of caspase-11 in mediating activation of caspase-1 and caspase-3 under pathological conditions. J Cell Biol (2000) 2.04
Femtosecond and subfemtosecond x-ray pulses from a self-amplified spontaneous-emission-based free-electron laser. Phys Rev Lett (2004) 2.02
A basal transcription factor that activates or represses transcription. Science (2000) 2.02
Measurements and simulations of ultralow emittance and ultrashort electron beams in the linac coherent light source. Phys Rev Lett (2009) 1.96
Susceptibility locus for inflammatory bowel disease on chromosome 16 has a role in Crohn's disease, but not in ulcerative colitis. Hum Mol Genet (1996) 1.93
The SAP, a new family of proteins, associate and function positively with the SIT4 phosphatase. Mol Cell Biol (1996) 1.93
Slow- and tight-binding inhibitors of the 85-kDa human phospholipase A2. Biochemistry (1993) 1.93
Strain-related differences in susceptibility to transient forebrain ischemia in SV-129 and C57black/6 mice. Stroke (1997) 1.89
Androgen-induced programs for prostate epithelial growth and invasion arise in embryogenesis and are reactivated in cancer. Oncogene (2008) 1.88
Dietary restriction and glucose regulation in aging rhesus monkeys: a follow-up report at 8.5 yr. Am J Physiol Endocrinol Metab (2001) 1.86
Diet and basal cell carcinoma of the skin in a prospective cohort of men. Am J Clin Nutr (2000) 1.85
atSRp30, one of two SF2/ASF-like proteins from Arabidopsis thaliana, regulates splicing of specific plant genes. Genes Dev (1999) 1.82
Multiple species of CPP32 and Mch2 are the major active caspases present in apoptotic cells. EMBO J (1997) 1.82
TCL1 shows a regulated expression pattern in chronic lymphocytic leukemia that correlates with molecular subtypes and proliferative state. Leukemia (2006) 1.79
Apoptosis-inducing factor is a major contributor to neuronal loss induced by neonatal cerebral hypoxia-ischemia. Cell Death Differ (2006) 1.77
The p55 subunit of Drosophila chromatin assembly factor 1 is homologous to a histone deacetylase-associated protein. Mol Cell Biol (1996) 1.75
Methyl arachidonyl fluorophosphonate: a potent irreversible inhibitor of anandamide amidase. Biochem Pharmacol (1997) 1.74
Cloning, expression, and function of TFC5, the gene encoding the B" component of the Saccharomyces cerevisiae RNA polymerase III transcription factor TFIIIB. Proc Natl Acad Sci U S A (1995) 1.73
Review: biocatalytic transformations of ferulic acid: an abundant aromatic natural product. J Ind Microbiol (1995) 1.71
MFR, a putative receptor mediating the fusion of macrophages. Mol Cell Biol (1998) 1.64
The Tat protein of human immunodeficiency virus type 1 is a substrate and inhibitor of the interferon-induced, virally activated protein kinase, PKR. J Biol Chem (1997) 1.63
Neuronal nitric oxide synthase activation and peroxynitrite formation in ischemic stroke linked to neural damage. J Neurosci (1999) 1.59
Cellular adherence elicits ligand-independent activation of the Met cell-surface receptor. Proc Natl Acad Sci U S A (1996) 1.58
Molecular determinants of the caspase-promoting activity of Smac/DIABLO and its role in the death receptor pathway. J Biol Chem (2000) 1.58
Purification and cDNA cloning of HeLa cell p54nrb, a nuclear protein with two RNA recognition motifs and extensive homology to human splicing factor PSF and Drosophila NONA/BJ6. Nucleic Acids Res (1993) 1.57
Serious complications associated with stereotactic ablative radiotherapy and strategies to mitigate the risk. Clin Oncol (R Coll Radiol) (2013) 1.56
The human SWI-SNF complex protein p270 is an ARID family member with non-sequence-specific DNA binding activity. Mol Cell Biol (2000) 1.54
Physical interaction of mammalian CDC37 with CDK4. J Biol Chem (1996) 1.53
Clara cell protein correlation with hyperlipidemia. Chest (1996) 1.52
Regulation of transcription at the Saccharomyces cerevisiae start transition by Stb1, a Swi6-binding protein. Mol Cell Biol (1999) 1.52
Generation of constitutively active recombinant caspases-3 and -6 by rearrangement of their subunits. J Biol Chem (1998) 1.52
The Orc4p and Orc5p subunits of the Xenopus and human origin recognition complex are related to Orc1p and Cdc6p. J Biol Chem (1998) 1.51
The matrix attachment region-binding protein SATB1 participates in negative regulation of tissue-specific gene expression. Mol Cell Biol (1997) 1.50
The large subunit of basal transcription factor SNAPc is a Myb domain protein that interacts with Oct-1. Mol Cell Biol (1998) 1.50
The type 2C Ser/Thr phosphatase PP2Cgamma is a pre-mRNA splicing factor. Genes Dev (1999) 1.49
Activities of adenovirus virus-associated RNAs: purification and characterization of RNA binding proteins. Proc Natl Acad Sci U S A (1998) 1.48
Water permeability of high-flux dialyzer membranes after Renalin reprocessing. Kidney Int (2007) 1.48
Diagnosis of genetic disease by primer-specified restriction map modification, with application to cystic fibrosis and retinitis pigmentosa. Lancet (1991) 1.48
Molecular cloning and characterization of p56dok-2 defines a new family of RasGAP-binding proteins. J Biol Chem (1998) 1.48
p300/CREB binding protein-related protein p270 is a component of mammalian SWI/SNF complexes. Mol Cell Biol (1998) 1.47
Serine phosphorylation-dependent association of the band 4.1-related protein-tyrosine phosphatase PTPH1 with 14-3-3beta protein. J Biol Chem (1997) 1.44
A new cyclophilin and the human homologues of yeast Prp3 and Prp4 form a complex associated with U4/U6 snRNPs. RNA (1997) 1.43
Physiologic and pathologic drug resistance in ovarian carcinoma--a hypothesis based on a clonal progression model. Acta Oncol (1998) 1.43
Interaction of the nuclear matrix-associated region (MAR)-binding proteins, SATB1 and CDP/Cux, with a MAR element (L2a) in an upstream regulatory region of the mouse CD8a gene. J Biol Chem (1997) 1.43